Therapixel Overview

  • Founded

  • 2013

Founded
  • Status

  • Private

  • Employees

  • 35

Employees
  • Latest Deal Type

  • 2ndary - Private

  • Investors

  • 21

Therapixel General Information

Description

Developer of a medical imaging technology intended to deliver pertinent information at the right time to healthcare professionals. The company's technology relies on in-depth sensing, research algorithms, and user interfaces to provide touchless information systems that comply with sterility constraints, enabling surgeons to access medical images, acquired before or during surgery, in order to make proper decisions on the health of the patient.

Contact Information

Website
www.therapixel.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 455 Promenade des Anglais
  • 06200 Nice
  • France
+33 09 00 00 00 00

Therapixel Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Therapixel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 000.00 Completed Generating Revenue
7. Later Stage VC (Series B) 12-May-2022 000.00 000.00 000.00 Completed Generating Revenue
6. Later Stage VC (Series A) 07-Nov-2018 00.000 00.000 000.00 Completed Generating Revenue
5. Grant 05-Jun-2017 00.000 00000 Completed Generating Revenue
4. Grant 00000 Completed Generating Revenue
3. Early Stage VC 10-Nov-2015 00000 00000 00.000 Completed Generating Revenue
2. Seed Round Completed Startup
1. Accelerator/Incubator 03-Jun-2013 Completed Startup
To view Therapixel’s complete valuation and funding history, request access »

Therapixel Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
ABSA 000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 000,000 00.000000 00.00 00.00 00 00.00 00.000
O 000,000 00.000000 00.00 00.00 00.00 0.000
O 233,901 $0.106673
O 688,513 $0.106673
To view Therapixel’s complete cap table history, request access »

Therapixel Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a medical imaging technology intended to deliver pertinent information at the right time to healthcare prof
Decision/Risk Analysis
Nice, France
35 As of 2022
000.00
000000 - 000 000.00

00000

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ali
0000000000000 00000000
Seoul, South Korea
000 As of 0000
00000
00000000 00000

000000

na aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
0000000000000 00000000
Nijmegen, Netherlands
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Therapixel Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lunit Venture Capital-Backed Seoul, South Korea 000 00000 00000000 00000
00000000000 000000 Venture Capital-Backed Nijmegen, Netherlands 00 000.00 00000000000 000.00
00000000000.00 Venture Capital-Backed Santa Clara, CA 000 0000 00000000000 0000
0000 0000000 00000 Venture Capital-Backed Tel Aviv, Israel 00 000.00 0000 000.00
0000000000 Venture Capital-Backed La Jolla, CA 00 00000000000
You’re viewing 5 of 8 competitors. Get the full list »

Therapixel Executive Team (5)

Name Title Board Seat Contact Info
Matthieu Leclerc-Chalvet Chief Executive Officer, Managing Director & Board Member
Pierre Fillard Co-Founder, Chief Science Officer & Board Member
Thomas Bertinotti Chief Product Officer
You’re viewing 3 of 5 executive team members. Get the full list »

Therapixel Board Members (5)

Name Representing Role Since
Alexandre Loiseau Ph.D Elaia Partners Chairman 000 0000
Matthieu Leclerc-Chalvet Therapixel Chief Executive Officer, Managing Director & Board Member 000 0000
Pierre Fillard Therapixel Co-Founder, Chief Science Officer & Board Member 000 0000
You’re viewing 3 of 5 board members. Get the full list »

Therapixel Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Therapixel Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CapHorn Invest Venture Capital Minority 000 0000 000000 0
Crédit Mutuel Innovation Venture Capital Minority 000 0000 000000 0
Sham Innovation Santé Corporate Venture Capital Minority 000 0000 000000 0
Verve Equity Partners PE/Buyout Minority 000 0000 000000 0
Verve Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 21 investors. Get the full list »

Ready to get started?

Request a free trial